Kalender next 42tg

Dienstag September 16 - All Day
Dank-, Buss- und Bettag
Sonntag September 21 - All Day
Herbst Tag/Nachtgleiche

Event Kalender

August 2025
Mo Di Mi Do Fr Sa So
28 29 30 31 1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Banners

Titel Hypocholesterolemic efficacy of royal jelly in healthy mild hypercholesterolemic adults
Subtitel
Author Hui-Fang Chiu, Bo-Kai Chen, Yan-Ying Lu, Yi-Chun Han, You-Cheng Shen, Kamesh Venkatakrishnan, Oksana Golovinskaia, and Chin-Kun Wang
Abstract Context: Royal jelly (RJ) has been reported for its health promoting factors such as antioxidant, anti-inflammatory and lipid lowering activities.

Objective: The present randomized, placebo-controlled study examines the hypolipidemic beneficial effect of RJ through evaluating anthropometric measurements, lipid profile and various hormone levels in mildly hypercholesterolemic participants.

Materials and methods: Forty subjects with mild hypercholesterolemia (180–200 mg/dL) were randomly selected and divided into two groups as experimental or placebo, who requested to intake nine capsules (350 mg/capsule) of RJ or placebo/day, respectively, for three months with one month of follow-up without any supplementation.

Results: No significant changes were noted in any of the anthropometric parameters like body weight, waist and body fat. The serum total cholesterol (TC; 207.05–183.15 mg/dL) and low-density lipoprotein cholesterol (LDL-c; 126.44–120.31 mg/dL) levels were reduced significantly (p < 0.05) after administration of RJ. However, triglyceride (TG) and high-density lipoprotein cholesterol (HDL-c) levels were not considerably altered. Moreover, three months of RJ consumption significantly ameliorated (p < 0.05) the concentration of sex hormones like dehydroepiandrosterone sulphate (DHEA-S; 1788.09–1992.31 ng/mL). Also, intake of RJ did not elicit any hepatic or renal damage.

Discussion and conclusion: Intervention with RJ for three months considerably lowered the TC and LDL-c levels through improving the levels of DHEA-S and thus alleviates the risk of cardiovascular disease (CVD).
Methods
Results
Conclusions
dx.doi.org / URL http://dx.doi.org/10.1080/13880209.2016.1253110
Published  Pharmaceutical Biology Volume 55, 2017 -  Issue 1
Attachments:
FileDescriptionFile sizeDownloads
Download this file (13880209.2016.1253110.pdf)13880209.2016.1253110.pdf 874 kB2036

Phänologie

aktualisierte Beiträge

Wetter

who is online

Aktuell sind 514 Gäste, 56 Bots und keine Mitglieder online


56 Bots:
20 x bingbot
15 x DotBot
9 x SemrushBot
5 x Majestic Bot
4 x Facebook Bot
3 x AhrefsBot